title: Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients.
authors.forename: Pimjai
authors.initials: P
authors.lastname: Niparuck
authors.forename: Wasana
authors.initials: W
authors.lastname: Kanoksil
authors.forename: Suporn
authors.initials: S
authors.lastname: Chuncharunee
authors.forename: Paisarn
authors.initials: P
authors.lastname: Boonsakan
authors.forename: Artit
authors.initials: A
authors.lastname: Ungkanont
authors.forename: Pantep
authors.initials: P
authors.lastname: Angchaisuksiri
authors.forename: Kanlaya
authors.initials: K
authors.lastname: Karntisaviwat
authors.forename: Axara
authors.initials: A
authors.lastname: Apilugsanachit
authors.forename: Budsaba
authors.initials: B
authors.lastname: Rerkamnuatchoke
authors.forename: Saengsuree
authors.initials: S
authors.lastname: Jootar
authors.forename: Prawat
authors.initials: P
authors.lastname: Nitiyanant
authors.forename: Vichai
authors.initials: V
authors.lastname: Atichartakarn
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced* / Q000175:diagnosis / Q000453:epidemiology; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000139:chemically induced* / Q000175:diagnosis / Q000453:epidemiology; D016609:Neoplasms, Second Primary / Q000139:chemically induced / Q000175:diagnosis / Q000453:epidemiology; D011379:Prognosis; D012189:Retrospective Studies; D013785:Thailand / Q000453:epidemiology; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents; D014740:Vidarabine; C024352:fludarabine